Atlas Trials

Zelquistinel in the Treatment of Major Depressive Disorder

Clinical trial NCT03586427 · COMPLETED

Trial details

NCT number
NCT03586427
Sponsor
Syndeio Biosciences, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Depressive Disorder, Major
Start date
2018-06-13
Primary completion
2019-07-22
Enrollment
251

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.